Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 71,946

Sort by:

Pancreatic Diseases Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pancreatic Diseases Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pancreatic Diseases Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 81 pages

Pancreatic Ductal Adenocarcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Pancreatic Ductal Adenocarcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pancreatic Ductal Adenocarcinoma Drugs in Development by Stages, Target, MoA, R...

May 2022 254 pages

Pancreatic Endocrine Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pancreatic Endocrine Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pancreatic Endocrine Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 37 pages

Pancreatic Islet Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pancreatic Islet Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pancreatic Islet Transplant Rejection Drugs in Development by Stages, Targ...

May 2022 41 pages

Pandemic Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pandemic Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pandemic Influenza Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 81 pages

Panic Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Panic Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Panic Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 38 pages

Papillary Renal Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Papillary Renal Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Papillary Renal Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA,...

May 2022 42 pages

Papillary Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Papillary Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Papillary Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 64 pages

Papillary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Papillary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Papillary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 36 pages

Paraganglioma (Glomus Jugulare Tumor) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Paraganglioma (Glomus Jugulare Tumor) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Paraganglioma (Glomus Jugulare Tumor) Drugs in Development by Stages, Targ...

May 2022 42 pages

Paralysis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Paralysis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Paralysis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...

May 2022 44 pages

Paramyxoviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Paramyxoviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Paramyxoviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 249 pages

Paranasal Sinus And Nasal Cavity Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Paranasal Sinus And Nasal Cavity Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Paranasal Sinus And Nasal Cavity Cancer Drugs in Development by Stages,...

May 2022 40 pages

Parathyroid Hormone-Parathyroid Hormone Related Peptide Receptor (PTH-PTHrP Type I Receptor or Parathyroid Hormone 1 Receptor or PTH1R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Parathyroid Hormone-Parathyroid Hormone Related Peptide Receptor (PTH-PTHrP Type I Receptor or Parathyroid Hormone 1 Receptor or PTH1R) Drugs in Development by Therapy Areas and Indications, Stages, M...

May 2022 38 pages

Partial Seizure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Partial Seizure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Partial Seizure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 46 pages

Pediatric Diffuse Intrinsic Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pediatric Diffuse Intrinsic Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pediatric Diffuse Intrinsic Pontine Glioma Drugs in Development by St...

May 2022 88 pages

Pemphigus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pemphigus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pemphigus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...

May 2022 48 pages

Penicillin Binding Protein 2 (PBP2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Penicillin Binding Protein 2 (PBP2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Penicillin Binding Protein 2 (PBP2) Drugs in Developm...

May 2022 40 pages

Penile Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Penile Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Penile Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 70 pages

Peptidyl Prolyl Cis Trans Isomerase (EC 5.2.1.8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Peptidyl Prolyl Cis Trans Isomerase (EC 5.2.1.8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Peptidyl Prolyl Cis Trans Isomerase (EC...

May 2022 49 pages

Periodontal Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Periodontal Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Periodontal Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 62 pages

Periostin (Osteoblast Specific Factor 2 or POSTN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Periostin (Osteoblast Specific Factor 2 or POSTN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Periostin (Osteoblast Specific Factor 2...

May 2022 37 pages

Peripheral Artery Occlusive Disease (PAOD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Peripheral Artery Occlusive Disease (PAOD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Peripheral Artery Occlusive Disease (PAOD) Drugs in Development by St...

May 2022 84 pages

Peripheral Myelin Protein 22 (Growth Arrest Specific Protein 3 or GAS3 or PMP22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Peripheral Myelin Protein 22 (Growth Arrest Specific Protein 3 or GAS3 or PMP22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Peripher...

May 2022 36 pages

Peripheral Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Peripheral Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Peripheral Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 39 pages

Peripheral Neuropathic Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Peripheral Neuropathic Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Peripheral Neuropathic Pain Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 122 pages

Peripheral Neuropathy (Sensory Neuropathy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Peripheral Neuropathy (Sensory Neuropathy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Peripheral Neuropathy (Sensory Neuropathy) Drugs in Development by St...

May 2022 74 pages

Peripheral T-Cell Lymphomas (PTCL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Peripheral T-Cell Lymphomas (PTCL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Peripheral T-Cell Lymphomas (PTCL) Drugs in Development by Stages, Target, Mo...

May 2022 165 pages

Peroxisome Proliferator Activated Receptor Alpha (Nuclear Receptor Subfamily 1 Group C Member 1 or NR1C1 or PPARA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Peroxisome Proliferator Activated Receptor Alpha (Nuclear Receptor Subfamily 1 Group C Member 1 or NR1C1 or PPARA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Typ...

May 2022 56 pages

Peroxisome Proliferator Activated Receptor Gamma (Nuclear Receptor Subfamily 1 Group C Member 3 or NR1C3 or PPARG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Peroxisome Proliferator Activated Receptor Gamma (Nuclear Receptor Subfamily 1 Group C Member 3 or NR1C3 or PPARG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Typ...

May 2022 71 pages

Persistent Corneal Epithelial Defects Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Persistent Corneal Epithelial Defects Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Persistent Corneal Epithelial Defects Drugs in Development by Stages, Targ...

May 2022 40 pages

Pervasive Developmental Disorder (PDD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Pervasive Developmental Disorder (PDD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pervasive Developmental Disorder (PDD) Drugs in Development by Stages, Ta...

May 2022 173 pages

Phosphatidylinositol 3 Kinase (PI3K or EC 2.7.1.137) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Phosphatidylinositol 3 Kinase (PI3K or EC 2.7.1.137) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Phosphatidylinositol 3 Kinase (PI3K...

May 2022 170 pages

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Delta Isoform (PI3K-Delta or Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Delta or PIK3CD or EC 2.7.1.137 or EC 2.7.1.153) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Delta Isoform (PI3K-Delta or Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Delta or PIK3CD or EC 2.7.1.137 o...

May 2022 79 pages

Phosphodiesterase 3 (PDE3 or EC 3.1.4.17) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Phosphodiesterase 3 (PDE3 or EC 3.1.4.17) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Phosphodiesterase 3 (PDE3 or EC 3.1.4.17) Drugs...

May 2022 41 pages

Phosphodiesterase 9 (PDE9 or EC 3.1.4.35) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Phosphodiesterase 9 (PDE9 or EC 3.1.4.35) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Phosphodiesterase 9 (PDE9 or EC 3.1.4.35) Drugs...

May 2022 36 pages

Phospholipase A2 (PLA2 or Lecithinase A or Phosphatidase or EC 3.1.1.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Phospholipase A2 (PLA2 or Lecithinase A or Phosphatidase or EC 3.1.1.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Phospholipase A2...

May 2022 53 pages

Pick Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pick Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pick Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 35 pages

Pituitary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pituitary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pituitary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 35 pages

Plaque Psoriasis (Psoriasis Vulgaris) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Plaque Psoriasis (Psoriasis Vulgaris) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Plaque Psoriasis (Psoriasis Vulgaris) Drugs in Development by Stages, Targ...

May 2022 159 pages

Plasma Cell Neoplasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Plasma Cell Neoplasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Plasma Cell Neoplasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 40 pages

Plasma Kallikrein (Fletcher Factor or Kininogenin or Plasma Prekallikrein or KLKB1 or EC 3.4.21.34) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Plasma Kallikrein (Fletcher Factor or Kininogenin or Plasma Prekallikrein or KLKB1 or EC 3.4.21.34) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Playe...

May 2022 49 pages

Plasminogen (Plasmin or PLG or EC 3.4.21.7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Plasminogen (Plasmin or PLG or EC 3.4.21.7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Plasminogen (Plasmin or PLG or EC 3.4.21.7) D...

May 2022 51 pages

Plasmodium falciparum 25 kDa Ookinete Surface Antigen (Pfs25) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Plasmodium falciparum 25 kDa Ookinete Surface Antigen (Pfs25) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Plasmodium falciparum 25 kD...

May 2022 36 pages

Plasmodium falciparum Circumsporozoite Protein (CSP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Plasmodium falciparum Circumsporozoite Protein (CSP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Plasmodium falciparum Circumsporozoi...

May 2022 45 pages

Plasmodium falciparum Merozoite Surface Protein 1 (Merozoite Surface Antigens or PMMSA or p190 or MSP1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Plasmodium falciparum Merozoite Surface Protein 1 (Merozoite Surface Antigens or PMMSA or p190 or MSP1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key P...

May 2022 36 pages

Platelet Derived Growth Factor Receptor (PDGFR or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Platelet Derived Growth Factor Receptor (PDGFR or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Platelet Derived Growth Fa...

May 2022 101 pages

Platelet Glycoprotein VI (Glycoprotein 6 or Platelet Collagen Receptor or GPVI or GP6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Platelet Glycoprotein VI (Glycoprotein 6 or Platelet Collagen Receptor or GPVI or GP6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Pl...

May 2022 37 pages

Pleomorphic Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Pleomorphic Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Pleomorphic Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 48 pages

Plexiform Neurofibroma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Plexiform Neurofibroma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Plexiform Neurofibroma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 37 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...